Before disclosing the cloning breakthrough, patent applications were filed and research papers prepared for publication. PPL Therapeutics, a small biotechnology company will be assigned the patent. After the cloning announcement, shares of PPL Therapeutics jumped 16% in one day on the London Stock Exchange.
March 13, 1997
Dolly: Clone or Commodity?
RAFI Follows the Money
Please consider supporting ETC's unique research and advocacy with a tax-deductible donation. Donate here